Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 23 | 0 | 2 | €0.001 | - | - |
| Moleculin Biotech Inc | 4 | 26 | 2 | 1 | €0.41 | €16.50 | 3923.805% |
| Evoke Pharma Inc. | 0 | 22 | 0 | 1 | €0.47 | - | - |
| Neptune Wellness Solutions Inc | 0 | 15 | 0 | 2 | €0.14 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 15 | 0 | 2 | €0.064 | - | - |
| Trevena Inc. | 1 | 14 | 1 | 3 | €0.44 | €8.37 | 1794.994% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €1.10 | €3.00 | 172.727% |
| Nymox Pharmaceutical Corp. | 0 | 4 | 0 | 0 | €0.23 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.34 | €7.00 | 199.145% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.99 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.95 | €6.49 | 580.821% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 1 | €0.62 | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.56 | - | - |
| Fibrogen Inc. | 2 | 4 | 1 | 1 | €1.07 | €0.000 | -100.000% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 1 | €0.63 | €3.00 | 374.533% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €3.18 | - | - |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €28.34 | - | - |
| Immuron | 0 | 1 | 0 | 1 | €2.18 | - | - |
| Sangamo Therapeutics Inc. | 11 | 12 | 0 | 1 | €0.48 | €2.79 | 481.820% |
| Agenus Inc. | 2 | 3 | 0 | 1 | €0.41 | €7.30 | 1664.911% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.90 | - | - |
| Adaptimmune Therapeutics PLC ADR | 1 | 2 | 0 | 2 | €0.92 | €1.25 | 36.612% |
| Aurinia Pharmaceuticals Inc. | 0 | 1 | 0 | 1 | €4.70 | - | - |